-
Something wrong with this record ?
Do human B-lymphocytes avoid aging until 60 years
A. Knight, P. Nemec, S. Bretzova, L. Valkova, M. Kolmanova, R. Vytopilova, M. Havelka, P. Vsianska, L. Rihova, M. Krejci, M. Piskacek,
Language English Country United States
Document type Journal Article
Grant support
NT14310
MZ0
CEP Register
NV15-32935A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Source
Source
NLK
Free Medical Journals
from 2010
Freely Accessible Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
Open Access Digital Library
from 2010-01-01
- MeSH
- Adaptive Immunity genetics immunology MeSH
- B-Lymphocytes immunology metabolism MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Immunity, Innate genetics immunology MeSH
- Interleukin-7 Receptor alpha Subunit genetics immunology metabolism MeSH
- Gene Expression Profiling methods MeSH
- Aging genetics immunology MeSH
- Transcriptome genetics immunology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Broad changes in human innate and adaptive immunity are associated with advanced age. The age-related alteration of gene expression was reported for both T and B lymphocytes. We analysed the genome-wide expression profiles (n=20) of naive and whole B cell populations from young and early aged healthy donors under 60 years. We revealed large homogeneity of all analysed genome-wide expression profiles but did not identified any significant gene deregulation between young (30-45 years) and early aged healthy donors (50-60 years). We argue that B cells avoid the aging program on molecular level until 60 years of age. Our results demonstrate the potential of hematopoietic stem cells to generate uncompromised lymphocytes in early elderly. These are very encouraging findings for the general health and the immunity maintenance would not need any intervention to naive B cells. Rather, a suitable immune stimulation in healthy body environment warrants further research into aging of older elderly.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011144
- 003
- CZ-PrNML
- 005
- 20201111091051.0
- 007
- ta
- 008
- 180404s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.18632/oncotarget.10146 $2 doi
- 035 __
- $a (PubMed)27344181
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Knight, Andrea $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. Gamma-Delta T Cell Laboratory, University Hospital Brno, Brno, Czech Republic.
- 245 10
- $a Do human B-lymphocytes avoid aging until 60 years / $c A. Knight, P. Nemec, S. Bretzova, L. Valkova, M. Kolmanova, R. Vytopilova, M. Havelka, P. Vsianska, L. Rihova, M. Krejci, M. Piskacek,
- 520 9_
- $a Broad changes in human innate and adaptive immunity are associated with advanced age. The age-related alteration of gene expression was reported for both T and B lymphocytes. We analysed the genome-wide expression profiles (n=20) of naive and whole B cell populations from young and early aged healthy donors under 60 years. We revealed large homogeneity of all analysed genome-wide expression profiles but did not identified any significant gene deregulation between young (30-45 years) and early aged healthy donors (50-60 years). We argue that B cells avoid the aging program on molecular level until 60 years of age. Our results demonstrate the potential of hematopoietic stem cells to generate uncompromised lymphocytes in early elderly. These are very encouraging findings for the general health and the immunity maintenance would not need any intervention to naive B cells. Rather, a suitable immune stimulation in healthy body environment warrants further research into aging of older elderly.
- 650 _2
- $a adaptivní imunita $x genetika $x imunologie $7 D056704
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a stárnutí $x genetika $x imunologie $7 D000375
- 650 _2
- $a B-lymfocyty $x imunologie $x metabolismus $7 D001402
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a stanovení celkové genové exprese $x metody $7 D020869
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a přirozená imunita $x genetika $x imunologie $7 D007113
- 650 _2
- $a receptor interleukinu-7 - alfa-podjednotka $x genetika $x imunologie $x metabolismus $7 D053699
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a transkriptom $x genetika $x imunologie $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nemec, Pavel $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
- 700 1_
- $a Bretzova, Sona $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. Laboratory of Cancer Biology and Genetics, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Valkova, Lucie $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. Laboratory of Cancer Biology and Genetics, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Kolmanová, Markéta $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. Laboratory of Cancer Biology and Genetics, University Hospital Brno, Brno, Czech Republic. $7 xx0213402
- 700 1_
- $a Vytopilova, Renata $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. Laboratory of Cancer Biology and Genetics, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Havelka, Marek $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. Laboratory of Cancer Biology and Genetics, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Vsianska, Pavla $u Department of Clinical Haematology, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Říhová, Lucie $u Department of Clinical Haematology, University Hospital Brno, Brno, Czech Republic. $7 xx0081970
- 700 1_
- $a Krejčí, Marta, $u Department of Internal Medicine, Haematology and Oncology, University Hospital Brno, Brno, Czech Republic. $d 1969- $7 jx20080512017
- 700 1_
- $a Piskáček, Martin $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. Laboratory of Cancer Biology and Genetics, University Hospital Brno, Brno, Czech Republic. $7 xx0213400
- 773 0_
- $w MED00184852 $t Oncotarget $x 1949-2553 $g Roč. 7, č. 28 (2016), s. 42873-42880
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27344181 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20201111091047 $b ABA008
- 999 __
- $a ok $b bmc $g 1288629 $s 1007956
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 7 $c 28 $d 42873-42880 $i 1949-2553 $m Oncotarget $n Oncotarget $x MED00184852
- GRA __
- $a NT14310 $p MZ0
- GRA __
- $a NV15-32935A $p MZ0
- LZP __
- $a Pubmed-20180404